ÎçÒ¹¸£Àû1000¼¯ºÏ

A new class of Alzheimer’s drugs has been shown to slow the condition’s progression by removing clumps of protein known as amyloid plaques from the brain. However, few countries have approved use of the medications as they bring only modest improvements, are expensive and can have serious side effects. Discover more about these controversial drugs and how they have changed our understanding of Alzheimer’s disease.